{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} ZURZUVAE - The First Oral Treatment Approved for Postpartum Depression

Activity Steps

1 Activity
2 Take Test 3Certificate

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Choose the risk factors for and the risks resulting from postpartum depression.
  2. Identify the potential adverse effects of the allopregnanolone agonists brexanolone and zuranolone (Zurzuvae).
  3. Select the appropriate actions for the administration of Zurzuvae.
  4. Recognize the duration of effectiveness of the two-week course of Zurzuvae.

Learning Outcomes

The majority of the participants of this activity will demonstrate knowledge of postpartum depression and the pharmacologic approaches to treating it by achieving a passing score on the posttest.

Disclosures

The author and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $17.95

Credits:

  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH
  • NM - BON 1.5 CH
  • SC - BON 1.5 CH
  • WV - BOERN 1.5 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Planner
Test Code: CNS0124
Published: Jan/Feb 2024
Expires: 3/7/2025
Sources: Clinical Nurse Specialist: The Journal for Advanced Nursing Practice
Required Passing Score: 8/10 (80%)
Authors: Patricia Anne O'Malley, PhD, APRN-CNS
Categories: Advanced Practice Nursing , Drug Therapy , Gynecological , Obstetrics , Psychosocial/Psychiatric , Women's Health
Specialties: Advanced Practice Nursing, Gynecology, Maternal-Child, OB/GYN, Obstetrics, Psychiatric and Mental Health, Women's Health
Topics: Drug Update , Mental Health , Postpartum Depression